A combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients with newly diagnosed chronic lymphocytic leukemia (CLL), according to researchers at The University of Texas MD Anderson ...
Jun 10, 2021
0
4
Although it was first reported in 1880, there has been little research conducted on prurigo nodularis (PN), an inflammatory chronic skin disorder characterized by firm, intensely itchy nodules that appear across the arms, ...
Jun 10, 2021
0
1
An international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della Svizzera italiana, has deciphered the T cell responses occurring during COVID-19 infection at single-cell ...
May 26, 2021
0
26
A Ludwig Cancer Research study has discovered how to revive a powerful but functionally inert subset of anti-cancer immune cells that are often found within tumors for cancer therapy.
May 24, 2021
0
173
A new study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes—immune system cells also known as helper T cells—produced by people who have received either of the two messenger RNA (mRNA) ...
Apr 22, 2021
1
265
People with cancers of the blood, bone marrow or lymph nodes are at an increased risk of not making protective coronavirus antibodies after COVID-19 vaccination, a new study warns.
Apr 12, 2021
0
4
Death from infection—the leading cause of death for patients with a common type of leukemia—is linked to specific gene mutations, a new study has found.
Apr 8, 2021
0
9
Children with Down syndrome are 20-times more likely to develop acute lymphocytic leukemia (ALL) and 150-times more likely to develop acute myeloid leukemia (AML) compared to their typical peers. According to a new study ...
Mar 31, 2021
0
18
Although Parkinson's disease affects around 1%-2% of people over the age of 65, there is currently no cure. And by the time it is diagnosed—typically by identifying problems with movement, such as slower movements and tremors—the ...
Mar 2, 2021
0
5
Treatments for beating tumors are mainly based on CD8 T lymphocytes, which specialize in detecting and eliminating intracellular infections and in killing cancer cells. A large proportion of patients, however, do not respond ...
Mar 1, 2021
0
83
